Synergistic inhibition of SARS-coronavirus replication by type I and type II IFN.
Mossel
Eric C
EC
Colorado State University, Fort Collins 80523, USA.
Sainz
Bruno
B
Garry
Robert F
RF
Peters
C J
CJ
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D002460:Cell Line; D002522:Chlorocebus aethiops; D006801:Humans; D007370:Interferon Type I / Q000235:genetics*; D016899:Interferon-beta / Q000378:metabolism; D007371:Interferon-gamma / Q000235:genetics* / Q000378:metabolism; D045473:Severe acute respiratory syndrome-related coronavirus / Q000235:genetics*; D013997:Time Factors; D014709:Vero Cells; D014779:Virus Replication
D000998:Antiviral Agents; D007370:Interferon Type I; D016899:Interferon-beta; D007371:Interferon-gamma